Otros idiomas TSH Biopharm Corporation Limited

Acciones

8432

TW0008432006

Precio de cierre Taipei Exchange Otros sitios de cotización 00:00:00 10/05/2024			Varia. Cinco días.	Varia. 1 de enero.
66 ^TWD	-1,64 %		+10,92 %	+31,21 %

07/05	TSH Biopharm Corporation Limited presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
11/03	TSH Biopharm Corporation Limited anuncia cambios de dirección el 1 de abril de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024	11/03
TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024	11/03
TSH Biopharm Corporation Limited agreed to acquire an unknown stake in TOP Pharm. Medicalware Company Limited from Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd., ANIMATO INTERNATIONAL COMPANY, Shen Feng Co., Ltd. and others for TWD 257.1 million.	11/03
TSH Biopharm Corporation Limited agreed to acquire 51% stake in TOP Biological Technology Company Limited from Shen Feng Co., Ltd., Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd. ANIMATO INTERNATIONAL COMPANY and others for TWD 44.3 million.	11/03
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
TSH Biopharm Corporation Limited Announces the Change of Financial Officer, Effective on January 1, 2024	14/12
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/08/23
Tsh Biopharm Corporation Limited Announces the Change of Audit Committee Members	25/05/23
Tsh Biopharm Corporation Limited Announces Dividend for the Year 2022, Payable on July 14, 2023	25/05/23
TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	04/05/23
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022	10/03/23
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022	10/03/23
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	03/11/22
TSH Biopharm : is invited to attend the online institutional investor conference hosted by IBF Securities	09/08/22
TSH Biopharm : Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2022	04/08/22
TSH Biopharm : Announcement of setting up the Sustainable Development Committee and members of TSH's first Sustainable Development Committee	04/08/22
TSH Biopharm Corporation Limited Announces Board Appointments	04/08/22
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	04/08/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas TSH Biopharm Corporation Limited

Acciones

8432

TW0008432006

Otros idiomas

Filtros